Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line

Leukemia Research

Volumn 22, Issue 8, 1998, Pages 663-670

  Sharma, Sunil ^a   Raymond, Eric ^a   Soda, Hiroshi ^a   Izbicka, Elzbieta ^a   Davidson, Karen ^a   Lawrence, Richard ^a   Von Hoff, Daniel D ^a  

^a CTRC Institute for Drug Development   (United States)

Author keywords

Cell cycle; DMSO; Lymphoma; Raji; Telomerase; Telomere

Indexed keywords

DIMETHYL SULFOXIDE; TELOMERASE;

ARTICLE; BURKITT LYMPHOMA; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; MITOSIS INHIBITION; PRIORITY JOURNAL; RAJI CELL;

BURKITT LYMPHOMA; CELL CYCLE; CELL DIVISION; DIMETHYL SULFOXIDE; ENZYME INHIBITORS; HUMANS; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0031844439     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00188-4     Document Type: Article

References (32)

1. Sawai M., Takase K., Teraoka H., Tsukada K. Reversible G1 arrest in the cell cycle of human lymphoid cell lines by dimethyl sulphoxide. Exp Cell Res. 187:1990;4-10.
2. Olvonikov A.M. A theory of marginotomy. J Theor Biol. 41:1971;181-190.
3. Watson J.D. Origin of concatameric T4 DNA. Nature. 239:1972;197-201.
4. McClintock B. The stability of broken ends of chromosomes. Genetics. 26:1941;234-282.
5. Harley C.B., Vaziri H., Counter C.M., Allsopp R.C. The telomere hypothesis of cellular aging. Exp Gerontol. 27:1992;375-382.
6. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during aging of human fibroblasts. Nature. 345:1990;458-460.
7. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., Harley C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 89:1992;10114-10118.
8. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
9. Harley C.B., Kim N.W., Prowse K.R., Weinrich S.L., Hirsch K.S., West M.D., Bacchetti S., Hirte H.W., Counter C.M., Greider CWet al. Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp Quant Biol. 59:1994;307-315.
10. Buchkovich K.J., Greider C.W. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell. 7:1996;1443-1454.
11. Xu D., Gruber A., Peterson C., Pisa P. Suppression of telomerase activity in HL-60 cells after treatment with differentiating agents. Leukemia. 10:1996;1354-1357.
12. Sharma H.W., Sokoloski J.A., Perez J.R., Maltese J.Y., Sartorelli A.C., Stein C.A., Nichols C.A., Khaled Z., Telang N.T., Naraynan R. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA. 92:1995;12343-12346.
13. Bestilny L.J., Brown C.B., Miura Y., Robertson L.D., Riabowol K.T. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res. 56:1996;3796-3802.
14. Albanell J., Han W., Mellado B., Gunawardane R., Scher H.I., Dmitrovsky E., Moore M.A.S. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant tumor cell lines. Cancer Res. 56:1996;1503-1508.
15. Holt S.E., Wright W.E., Shay J.W. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol. 16:1996;2932-2939.
16. Takase K., Sawai M., Yamamoto K., Yata J., Takasaki Y., Teraoka H., Tsukada K. Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: kinetics of the arrest and expression of the cell cycle marker proliferating cell nuclear antigen in Raji cells. Cell Growth Differ. 3:1992;515-521.
17. Teraoka H., Sawai M., Takase K., Yamamoto K., Nozaki N., Okazaki T., Tsukada K. Expression of c-fos and c-myc in Raji Burkitt's Lymphoma cells during the progression of DMSO-induced G1 cells into S phase. Exp Cell Res. 195:1991;274-276.
18. Shay JW, Brasiskyte D, Ouellete M, Piatyszek MA, Werbin H, Ying Y, Wright WE. Analysis of telomerase and telomeres. In: Adolph KW, editor. Methods in Molecular Genetics, vol. 5. Academic Press, 1994:263-280.
19. Sun D, Chen S-F, Von Hoff D. A sensitive and rapid assay method of human telomerase using dynabeads. In: Lobbezoo MW, editor. Ninth NCI-EORTC Symposium on New Drugs in Cancer Therapy. Dordrecht: Kluwer, 1996:71(A240).
20. Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol. 66:1975;188-195.
21. Teraoka H., Sawai M., Yamamoto K., Tsukada K. DNA ligase I mRNA and enzyme levels in human hematopoietic cells under dimethyl sulfoxide induce growth arrest and differentiation. Biochem Int. 26:1992;963-971.
22. Takase K., Terada N., Szepesi A., Teraoka H., Gelfand E.W., Lucas J.J. Release from G0/G1 arrest induced by dimethyl sulfoxide in human lymphoid cells: regulation of synthesis and activation of the p33cdk2 and p34cdc2 kinases. Cell Growth Differ. 5:1994;1051-1059.
23. Sharma S., Raymond E., Soda H., Sun D., Hilsenbeck S.G., Sharma A., Izbicka E., Windle B., Von Hoff D.D. Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Ann Oncol. 8:1997;1063-1074.
24. Bestilny L.J., Brown C.B., Miura Y., Robertson L.D., Riabowol K.T. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res. 56:1996;3796-3802.
25. Zhu X., Kumar R., Mandal M., Sharma N., Sharma H.W., Dhingra U., Sokoloski J.A., Hsiao R., Naraynan R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA. 93:1996;6091-6095.
26. Tarin D. Clinical investigation of telomerase activity as a marker for breast, bladder and colorectal cancer. In: Perry MC, editor. ASCO Educational Book. Philadelphia, PA: Saunders, 1997:57-63.
27. Engelhardt M., Kumar R., Albanell J., Pettengell R., Han W., Moore M.A.S. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood. 90:1997;182-193.
28. Kruk P.A., Balajee A.S., Rao K.S., Bohr V.A. Telomere reduction and telomerase inactivation during neuronal cell differentiation. Biochem Biophys Res Commun. 224:1996;487-492.
29. Yokoyama Y., Takahashi Y., Morishita S., Tamaya T. Over expression of p21Cip1/Waf1 reduces telomerase activity of HeLa cells. Proc Am Assoc Cancer Res. 37:1996;9.
30. Blasco MA, Lee H-W, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34.
31. Wynford-Thomas D, Kipling D. Cancer and the knockout mouse. Nature 389:551-552.
32. Zakian VA. Life and cancer without telomerase. Cell 91:1-3.